Literature DB >> 26168782

Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: A comparison between two modalities.

Tiina Seppälä1, Harri Visapää2, Juhani Collan2, Mika Kapanen2, Annette Beule3, Mauri Kouri2, Mikko Tenhunen2, Kauko Saarilahti2.   

Abstract

PURPOSE: To investigate the conversion of prostate cancer radiotherapy (RT) target definition from CT-based planning into an MRI-only-based planning procedure.
MATERIALS AND METHODS: Using the CT- and MRI-only-based RT planning protocols, 30 prostate cancer patients were imaged in the RT fixation position. Two physicians delineated the prostate in both CT and T2-weighted MRI images. The CT and MRI images were coregistered based on gold seeds and anatomic borders of the prostate. The uncertainty of the coregistration, as well as differences in target volumes and uncertainty of contour delineation were investigated. Conversion of margins and dose constraints from CT- to MRI-only-based treatment planning was assessed.
RESULTS: On average, the uncertainty of image coregistration was 0.4 ± 0.5 mm (one standard deviation, SD), 0.9 ± 0.8 mm and 0.9 ± 0.9 mm in the lateral, anterior-posterior and base-apex direction, respectively. The average ratio of the prostate volume between CT and MRI was 1.20 ± 0.15 (one SD). Compared to the CT-based contours, the MRI-based contours were on average 2-7 mm smaller in the apex, 0-1 mm smaller in the rectal direction and 1-4 mm smaller elsewhere.
CONCLUSION: When converting from a CT-based planning procedure to an MRI-based one, the overall planning target volumes (PTV) are prominently reduced only in the apex. The prostate margins and dose constraints can be retained by this conversion.

Entities:  

Keywords:  Bladder; Imaging; Intensity-modulated radiotherapy; Organs at risk; Rectum

Mesh:

Year:  2015        PMID: 26168782     DOI: 10.1007/s00066-015-0868-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  23 in total

1.  T1/T2*-weighted MRI provides clinically relevant pseudo-CT density data for the pelvic bones in MRI-only based radiotherapy treatment planning.

Authors:  Mika Kapanen; Mikko Tenhunen
Journal:  Acta Oncol       Date:  2012-06-19       Impact factor: 4.089

2.  MRI target delineation may reduce long-term toxicity after prostate radiotherapy.

Authors:  Lotte Sander; Niels Christian Langkilde; Mats Holmberg; Jesper Carl
Journal:  Acta Oncol       Date:  2013-12-20       Impact factor: 4.089

3.  Characterization of tissue magnetic susceptibility-induced distortions for MRIgRT.

Authors:  T Stanescu; K Wachowicz; D A Jaffray
Journal:  Med Phys       Date:  2012-12       Impact factor: 4.071

4.  Commissioning of MRI-only based treatment planning procedure for external beam radiotherapy of prostate.

Authors:  Mika Kapanen; Juhani Collan; Annette Beule; Tiina Seppälä; Kauko Saarilahti; Mikko Tenhunen
Journal:  Magn Reson Med       Date:  2012-08-10       Impact factor: 4.668

5.  Influence of MRI-based bone outline definition errors on external radiotherapy dose calculation accuracy in heterogeneous pseudo-CT images of prostate cancer patients.

Authors:  Juha Korhonen; Mika Kapanen; Jani Keyriläinen; Tiina Seppälä; Laura Tuomikoski; Mikko Tenhunen
Journal:  Acta Oncol       Date:  2014-07-07       Impact factor: 4.089

6.  A dual model HU conversion from MRI intensity values within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer.

Authors:  Juha Korhonen; Mika Kapanen; Jani Keyriläinen; Tiina Seppälä; Mikko Tenhunen
Journal:  Med Phys       Date:  2014-01       Impact factor: 4.071

7.  Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging alone.

Authors:  Young K Lee; Marc Bollet; Geoffrey Charles-Edwards; Maggie A Flower; Martin O Leach; Helen McNair; Elizabeth Moore; Carl Rowbottom; Steve Webb
Journal:  Radiother Oncol       Date:  2003-02       Impact factor: 6.280

8.  Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer.

Authors:  Buelent Polat; Iris Guenther; Juergen Wilbert; Joachim Goebel; Reinhart A Sweeney; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

9.  Investigation of MR image distortion for radiotherapy treatment planning of prostate cancer.

Authors:  Z Chen; C-M Ma; K Paskalev; J Li; J Yang; T Richardson; L Palacio; X Xu; L Chen
Journal:  Phys Med Biol       Date:  2006-02-21       Impact factor: 3.609

10.  Systematisation of spatial uncertainties for comparison between a MR and a CT-based radiotherapy workflow for prostate treatments.

Authors:  Tufve Nyholm; Morgan Nyberg; Magnus G Karlsson; Mikael Karlsson
Journal:  Radiat Oncol       Date:  2009-11-17       Impact factor: 3.481

View more
  8 in total

1.  Penile bulb sparing in prostate cancer radiotherapy : Dose analysis of an in-house MRI system to improve contouring.

Authors:  F Böckelmann; M Hammon; S Lettmaier; R Fietkau; C Bert; F Putz
Journal:  Strahlenther Onkol       Date:  2018-10-12       Impact factor: 3.621

Review 2.  Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?

Authors:  Ben G L Vanneste; Evert J Van Limbergen; Emile N van Lin; Joep G H van Roermund; Philippe Lambin
Journal:  Biomed Res Int       Date:  2016-12-28       Impact factor: 3.411

3.  Implementation of diffusion-weighted magnetic resonance imaging in target delineation of central lung cancer accompanied with atelectasis in precision radiotherapy.

Authors:  Xinli Zhang; Zheng Fu; Guanzhong Gong; Hong Wei; Jinghao Duan; Zhaoqiu Chen; Xiangming Chen; Ruozheng Wang; Yong Yin
Journal:  Oncol Lett       Date:  2017-06-23       Impact factor: 2.967

4.  Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer.

Authors:  Daniel R Henderson; Alison C Tree; Kevin J Harrington; Nicholas J van As
Journal:  Medicines (Basel)       Date:  2018-04-05

5.  Target definition in radiotherapy of prostate cancer using magnetic resonance imaging only workflow.

Authors:  Adalsteinn Gunnlaugsson; Emilia Persson; Christian Gustafsson; Elisabeth Kjellén; Petra Ambolt; Silke Engelholm; Per Nilsson; Lars E Olsson
Journal:  Phys Imaging Radiat Oncol       Date:  2019-03-20

6.  Determination of acceptance criteria for geometric accuracy of magnetic resonance imaging scanners used in radiotherapy planning.

Authors:  Henna Kavaluus; Katri Nousiainen; Sampsa Kaijaluoto; Tiina Seppälä; Kauko Saarilahti; Mikko Tenhunen
Journal:  Phys Imaging Radiat Oncol       Date:  2021-01-25

7.  Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR images.

Authors:  Emilia Persson; Sevgi Emin; Jonas Scherman; Christian Jamtheim Gustafsson; Patrik Brynolfsson; Sofie Ceberg; Adalsteinn Gunnlaugsson; Lars E Olsson
Journal:  Radiat Oncol       Date:  2021-08-16       Impact factor: 3.481

8.  Quantitative assessment of intra- and inter-modality deformable image registration of the heart, left ventricle, and thoracic aorta on longitudinal 4D-CT and MR images.

Authors:  Alireza Omidi; Elisabeth Weiss; John S Wilson; Mihaela Rosu-Bubulac
Journal:  J Appl Clin Med Phys       Date:  2021-12-27       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.